Corvus Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Corvus Pharmaceuticals is a biopharmaceutical company in the clinical stage that is dedicated to creating groundbreaking treatments for cancer by targeting the immune system. We have a team of skilled scientists and strong financial backing, which puts us in a prime position in the evolving field of immuno-oncology.
Corvus Pharmaceuticals has raised $232M across 2 funding rounds on record, the most recent an undisclosed round of $201M announced in Jan 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Corvus Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Corvus Pharmaceuticals Funding Rounds
Corvus Pharmaceuticals raised $30.6M in an undisclosed round announced in May 2024.
1.7 years later, an undisclosed round of $201M was announced in Jan 2026.
Corvus Pharmaceuticals Founders and Leadership Team
Contact details for the Corvus Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Corvus Pharmaceuticals Funding Compared to Other Biotechnology Startups
Corvus Pharmaceuticals' latest round of $201M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Corvus Pharmaceuticals in Biotechnology and Burlingame
Companies Similar to Corvus Pharmaceuticals
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Corvus Pharmaceuticals Funding FAQs
What does Corvus Pharmaceuticals do?
Corvus Pharmaceuticals is a biopharmaceutical company in the clinical stage that is dedicated to creating groundbreaking treatments for cancer by targeting the immune system. We have a team of skilled scientists and strong financial backing, which puts us in a prime position in the evolving field of immuno-oncology.
How much funding has Corvus Pharmaceuticals raised?
Corvus Pharmaceuticals has raised $232M across 2 rounds on record. The most recent is an undisclosed round of $201M announced in Jan 2026.
When did Corvus Pharmaceuticals last raise funding?
Corvus Pharmaceuticals' most recent funding round on record is an undisclosed round of $201M, announced in Jan 2026.
Who founded Corvus Pharmaceuticals?
FundedIQ lists Richard A Miller (Founder) at Corvus Pharmaceuticals.
Where is Corvus Pharmaceuticals headquartered?
Corvus Pharmaceuticals is based in Burlingame, California, United States.
How many employees does Corvus Pharmaceuticals have?
Corvus Pharmaceuticals is in the 11-50 employee band.
How does Corvus Pharmaceuticals' funding compare to other Biotechnology startups?
Corvus Pharmaceuticals' latest round of $201M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Corvus Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Corvus Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.